Jaguar Health logo

Jaguar Health Share Price Today

(NASDAQ: JAGX)

Jaguar Health share price is $0.59 & ₹51.37 as on 6 Mar 2025, 2.30 'hrs' IST

$0.59

0.02

(3.63%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Jaguar Health share price in Dollar and Rupees. Guide to invest in Jaguar Health stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Jaguar Health, along with analyst recommendations, forecasts, and comprehensive financials.

Jaguar Health share price movements

  • Today's Low: $0.57
    Today's High: $0.60

    Day's Volatility :4.77%

  • 52 Weeks Low: $0.55
    52 Weeks High: $21.60

    52 Weeks Volatility :97.45%

Jaguar Health (JAGX) Returns

PeriodJaguar Health IncIndex (Russel 2000)
3 Months
-40.25%
0.0%
6 Months
-47.26%
0.0%
1 Year
-89.01%
0.0%
3 Years
-99.97%
-11.6%

Jaguar Health (JAGX) Key Statistics

in dollars & INR

Previous Close
$0.57
Open
$0.5714
Today's High
$0.6
Today's Low
$0.5714
Market Capitalization
$9.3M
Today's Volume
$144.5K
52 Week High
$21.6
52 Week Low
$0.55
Revenue TTM
$10.5M
EBITDA
$-27.9M
Earnings Per Share (EPS)
$19.89
PE Ratio
0.03
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-450.92%

How to invest in Jaguar Health Stock (JAGX) from India?

It is very easy for Indian residents to invest directly in Jaguar Health from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Jaguar Health stock in both Indian Rupees (INR) and US Dollars (USD). Search for Jaguar Health or JAGX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Jaguar Health or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Jaguar Health shares which would translate to 1.476 fractional shares of Jaguar Health as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Jaguar Health, in just a few clicks!

Returns in Jaguar Health (JAGX) for Indian investors in Rupees

The Jaguar Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Jaguar Health investment value today

Current value as on today

₹16,031

Returns

₹83,969

(-83.97%)

Returns from Jaguar Health Stock

₹89,033 (-89.03%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Jaguar Health (JAGX)

-21%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Jaguar Health Stock from India on INDmoney has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Jaguar Health

  • Geode Capital Management, LLC

    0.59%

  • Vanguard Group Inc

    0.36%

  • UBS Group AG

    0.31%

  • HRT FINANCIAL LLC

    0.20%

  • State Street Corp

    0.09%

  • Virtu Financial LLC

    0.08%

Analyst Recommendation on Jaguar Health

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Jaguar Health(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Jaguar Health Stock (JAGX)

What analysts predicted

Upside of 916.95%

Target:

$6.00

Current:

$0.59

Insights on Jaguar Health Stock (Ticker Symbol: JAGX)

  • Price Movement

    In the last 1 month, JAGX stock has moved down by -30.1%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 2.35M → 3.10M (in $), with an average increase of 13.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -7.77M → -9.85M (in $), with an average decrease of 8.4% per quarter
  • JAGX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 155.5%
  • JAGX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 151.6%
  • Price to Sales

    ForJAGX every $1 of sales, investors are willing to pay $0.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Jaguar Health Technicals Summary

Sell

Neutral

Buy

Jaguar Health is currently in a neutral trading position according to technical analysis indicators.

Jaguar Health (JAGX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Jaguar Health Inc logo
-34.29%
-47.26%
-89.01%
-99.97%
-99.99%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Jaguar Health Inc logo
0.03
0.03
-0.02
0.0
-4.51
-0.36
NA
1.31
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Jaguar Health Inc logo
Buy
$9.3M
-99.99%
0.03
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Jaguar Health

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. The company's products include Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing NP-300, a second-generation antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea. The company is headquartered in San Francisco, California.
Organization
Jaguar Health
Employees
49
CEO
Ms. Lisa A. Conte
Industry
Health Technology

Management People of Jaguar Health

NameTitle
Ms. Lisa A. Conte
Founder, CEO, President & Director
Dr. Pravin R. Chaturvedi Ph.D.
Chief Scientific Officer & Chair of Scientific Advisory Board
Mr. Jonathan S. Wolin CPA, J.D., M.B.A.
Chief of Staff, Chief Compliance Officer & General Counsel
Dr. Steven R. King Ph.D.
Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Secretary
Ms. Carol R. Lizak M.B.A.
Chief Financial Officer
Mr. Peter Hodge
Senior Director of Investor Relations, Business Development & Special Events
Dr. Karen J. Brunke Ph.D.
Executive VP of Corporate & Business Development
Mr. David Sesin Ph.D.
Chief Manufacturing Officer
Mr. Ian H. Wendt M.B.A.
Chief Commercial Officer
Dr. Massimo Radaelli M.B.A., Ph.D.
President of Jaguar International

Important FAQs about investing in JAGX Stock from India :

What is Jaguar Health share price today?

Jaguar Health share price today stands at $0.59, Open: $0.57 ; Previous Close: $0.57 ; High: $0.60 ; Low: $0.57 ; 52 Week High: $21.60 ; 52 Week Low: $0.55.

The stock opens at $0.57, after a previous close of $0.57. The stock reached a daily high of $0.60 and a low of $0.57, with a 52-week high of $21.60 and a 52-week low of $0.55.

Can Indians buy Jaguar Health shares?

Yes, Indians can invest in the Jaguar Health (JAGX) from India.

With INDmoney, you can buy Jaguar Health at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Jaguar Health at zero transaction cost.

How can I buy Jaguar Health shares from India?

It is very easy to buy Jaguar Health from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Jaguar Health (JAGX) be purchased?

Yes, you can buy fractional shares of Jaguar Health with INDmoney app.

What are the documents required to start investing in Jaguar Health stocks?

To start investing in Jaguar Health, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Jaguar Health Stock (JAGX)?

Today’s highest price of Jaguar Health (JAGX) is $0.60.

Today’s lowest price of Jaguar Health (JAGX) is $0.57.

What is today's market capitalisation of Jaguar Health?

Today's market capitalisation of Jaguar Health JAGX is 9.3M

What is the 52 Week High and Low Range of Jaguar Health Stock (JAGX)?

  • 52 Week High

    $21.60

  • 52 Week Low

    $0.55

What are the historical returns of Jaguar Health (JAGX)?

  • 1 Month Returns

    -34.29%

  • 3 Months Returns

    -47.26%

  • 1 Year Returns

    -89.01%

  • 5 Years Returns

    -99.99%

Who is the Chief Executive Officer (CEO) of Jaguar Health ?

Ms. Lisa A. Conte is the current Chief Executive Officer (CEO) of Jaguar Health.